FTC sues drug middlemen for allegedly inflating insulin prices
[ad_1]
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
[ad_2]
Source link